Flavonoids as opioid receptor ligands: Identification and preliminary structure-activity relationships

被引:67
|
作者
Katavic, Peter L.
Lamb, Kenneth
Navarro, Hernan
Prisinzano, Thomas E. [1 ]
机构
[1] Univ Iowa, Coll Pharm, Div Med & Nat Prod Chem, Iowa City, IA 52242 USA
[2] Res Triangle Inst, Res Triangle Pk, NC 27709 USA
来源
JOURNAL OF NATURAL PRODUCTS | 2007年 / 70卷 / 08期
关键词
D O I
10.1021/np070194x
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Flavonoids have been recognized as the active ingredients of many medicinal plant extracts due to interactions with proteins via phenolic groups and low toxicity. Here, we report the investigation of the flavonoid core as a potential new scaffold for the development of opioid receptor ligands. Biological results suggest that stereochemistry of the C2 and C3 positions is important for antagonist activity and selectivity. Our results also suggest that the actions of Hypericum perforatum may be mediated in part by opioid receptors.
引用
收藏
页码:1278 / 1282
页数:5
相关论文
共 50 条
  • [41] Identification of New Nonsteroidal RORα Ligands; Related Structure-Activity Relationships and Docking Studies
    Dubernet, Mathieu
    Duguet, Nicolas
    Colliandre, Lionel
    Berini, Christophe
    Helleboid, Stephane
    Bourotte, Marilyne
    Daillet, Matthieu
    Maingot, Lucie
    Daix, Sebastien
    Delhomel, Jean-Francois
    Morin-Allory, Luc
    Routier, Sylvain
    Walczak, Robert
    ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (06): : 504 - 508
  • [42] Novel Ligands for human melanocortin receptor subtypes: Design, synthesis and structure-activity relationships
    Stankova, Magda
    Cai, Minying
    Cabello, Chris
    DeCot, Bridgette
    Krchnak, Victor, Jr.
    Hruby, Victor J.
    PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, 2004, : 649 - 650
  • [43] Synthesis and structure-activity relationships of new adenine derivatives as ligands for the rat adenine receptor
    Borrmann, Thomas
    Abdelrahman, Aliaa
    Gorzalka, Simone
    Schiedel, Anke
    Mueller, Christa E.
    PURINERGIC SIGNALLING, 2008, 4 : S13 - S13
  • [44] Novel ligands for human melanocortin receptor subtypes: Design, synthesis and structure-activity relationships
    Stankova, M
    Cai, M
    Cabello, C
    DeCot, B
    Krchnak, V
    Hruby, VJ
    BIOPOLYMERS, 2003, 71 (03) : 309 - 309
  • [45] Synthesis and structure-activity relationships of potent conformationally restricted retinoid X receptor ligands
    Farmer, LJ
    Zhi, L
    Jeong, S
    Kallel, EA
    Croston, G
    Flatten, KS
    Heyman, RA
    Nadzan, AM
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (21) : 2747 - 2752
  • [46] Quantitative structure-activity relationships of nicotine analogues as neuronal nicotinic acetylcholine receptor ligands
    Kim, KH
    Lin, NH
    Anderson, DJ
    BIOORGANIC & MEDICINAL CHEMISTRY, 1996, 4 (12) : 2211 - 2217
  • [47] MEDI 11-Synthesis and structure-activity relationships of a series of sigma receptor ligands
    Somu, Ravindranadh V.
    Wilson, Daniel
    Qiao, Chunhua
    Vannada, Jagadeswar
    Bennett, Eric
    Boshoff, Helena
    Barry, Clifton E., III
    Aldrich, Courtney C.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 850 - 850
  • [48] Synthesis and structure-activity relationships of naphthamides as dopamine D3 receptor ligands
    Huang, YS
    Luedtke, RR
    Freeman, RA
    Wu, L
    Mach, RH
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (11) : 1815 - 1826
  • [49] Structure-activity relationships of N-substituted ligands for the α7 nicotinic acetylcholine receptor
    Mortell, Kathleen H.
    Schrimpf, Michael R.
    Bunnelle, William H.
    Anderson, David J.
    Gronlien, Jens Halvard
    Hagene, Kirsten Thorin
    Gopalakrishnan, Murali
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (01) : 104 - 107
  • [50] Synthesis and structure-activity relationships of new non-steroidal progesterone receptor ligands
    Kurihara, K
    Tanabe, K
    Yamamoto, Y
    Shinei, R
    Ajito, K
    Okonogi, T
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (13) : 1837 - 1842